SCHEMBL753759

SCHEMBL753759

COCNC(=O)c1cnc(C)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
POLB P06746 3/20 0.59
HPGD P15428 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
ATM Q13315 1/20 0.59
TSHR P16473 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
NPC1 O15118 6/20 0.52
RAB9A P51151 5/20 0.52
TDP1 Q9NUW8 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1874036 0.80 NPC1 (0.54) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL6429451 0.79 NPC1 (0.55) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL10603927 0.78 NPC1 (0.54) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL10205813 0.78 L3MBTL1 (0.56) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL3344444 0.77 NPC1 (0.59) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL5235038 0.77 RAB9A (0.59) ALDH1A1POLBHPGDCYP1A2CYP3A4
SCHEMBL26048300 0.77 NPC1 (0.59) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL17298873 0.77 NPC1 (0.52) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL17052948 0.77 LMNA (0.55) ALDH1A1L3MBTL1POLBHPGDCYP1A2
SCHEMBL5309386 0.76 CYP3A4 (0.55) ALDH1A1L3MBTL1POLBHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 EP disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
EP-3042894-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2016-07-13 EP disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
EP-1422218-B1 ANTIVIRAL AGENT SHIONOGI & CO (JP) 2012-03-21 EP disclosed
EP-2181985-B1 Antiviral Agent SHIONOGI & CO (JP) 2011-10-26 EP disclosed
EP-2266958-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2010-12-29 EP disclosed
EP-2181985-A1 Antiviral Agent SHIONOGI & CO., LTD. (JP) 2010-05-05 EP disclosed
US-20040229909-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2004-11-18 US disclosed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229909-A1 Antiviral agent ZC3HAV1, ZC3HAV1L, DUT ALDH1A1 658/4885L3MBTL1 623/4885POLB 89/4885
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI ALDH1A1 424/4885L3MBTL1 1368/4885POLB 107/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI ALDH1A1 424/4885L3MBTL1 1368/4885POLB 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.